Merger with Kintara Therapeutics (Tables)

12 Months Ended

Dec. 31, 2024

Business Combinations [Abstract]

Schedule of Net Liabilities Assumed in Merger

The following table shows the net liabilities assumed in the merger:

	October 18,
	2024
Cash and cash equivalents	$	70,097
Prepaid and other assets		370,030
Accounts payable and accrued expenses		(1,787,039	)
Total net liabilities assumed		(1,346,912	)
Plus: merger transaction costs		(4,129,663	)
Total net liabilities assumed plus merger transaction costs	$	(5,476,575	)